Thane Wettig - Jun 6, 2025 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role
CEO, Director
Signature
/s/ Michael Hom, Attorney-in-Fact
Stock symbol
FGEN
Transactions as of
Jun 6, 2025
Transactions value $
-$4,928
Form type
4
Date filed
9/9/2025, 07:25 PM
Previous filing
Mar 25, 2025
Next filing
Nov 17, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wettig Thane CEO, Director C/O FIBROGEN, INC., 350 BAY STREET, SUITE 100, #6009, SAN FRANCISCO /s/ Michael Hom, Attorney-in-Fact 2025-09-09 0001815638

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Tax liability -$1.93K -246 -1.13% $7.83 21.5K Jun 6, 2025 Direct F1
transaction FGEN Common Stock Tax liability -$3K -248 -1.15% $12.10 21.2K Sep 6, 2025 Direct F1
holding FGEN Common Stock 40 Jun 6, 2025 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.

Remarks:

Share amount and share prices reflect a 1-for-25 reverse stock split effective on June 16, 2025.